SCHEMBL25528574

SCHEMBL25528574

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(-c3ccc(C)s3)c2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 15/20 0.50
THRA P10827 14/20 0.50
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.31
MPI P34949 1/20 0.31
KMT2A Q03164 1/20 0.31
AURKA O14965 1/20 0.31
JAK2 O60674 1/20 0.31
PAK4 O96013 1/20 0.31
NTRK1 P04629 1/20 0.31
FYN P06241 1/20 0.31
CSF1R P07333 1/20 0.31
RET P07949 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25527959 0.92 THRB (0.61) THRBTHRAMCL1
SCHEMBL25528569 0.83 THRB (0.50) THRBTHRAALDH1A1KDM4EHPGD
SCHEMBL25528572 0.83 THRB (0.50) THRBTHRAALDH1A1RAB9A
SCHEMBL25528706 0.81 THRA (0.57) THRBTHRAALDH1A1HPGDRAB9A
SCHEMBL25528579 0.80 THRA (0.51) THRBTHRAMCL1
SCHEMBL25528580 0.80 THRB (0.51) THRBTHRA
SCHEMBL25528523 0.80 THRA (0.51) THRBTHRA
SCHEMBL25528562 0.79 THRA (0.52) THRBTHRAPIM1
SCHEMBL25528584 0.78 THRB (0.49) THRBTHRAALDH1A1KDM4ECYP1A2
SCHEMBL25528577 0.78 THRA (0.51) THRBTHRAALDH1A1HPGDGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRB 9/4885THRA 4/4885ALDH1A1 1020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.